Other

We have participated in more than 1,200 clinical research trials (130 active trials) and have introduced most of the new techniques in cardiovascular medicine over the past 20 years.

Clinical Trials: Other

Description

Prospective, Open-Label Study of Andexanet Alfa in Patients Receiving a Factor Xa Inhibitor Who Have Acute Major Bleeding

Investigator(s): Kereiakes

Enrolling

An Open-Label, Non-Randomized, Single-Arm, Multi-Center Study to Evaluate Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections in Subjects for Whom Chronic Antibiotic Suppressive Therapy is Indicated

Investigator(s): Cafardi

Enrolling

Randomized controlled study of transversus abdominis plane blocks for postoperative pain control following major open abdominal procedures

Investigator(s): Vaughan

Enrolling

Safety and Effectiveness of the Spiration Valve System (SVS) in Air Leaks

Investigator(s): Lanka

Enrolling

Inspire® Upper Airway Stimulation System (UAS): Post-Approval Study Protocol Number 2014-001

Investigator(s): Hellmann

Pending

A Phase 2a Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients With Knee Osteoarthritis

Investigator(s): Swank

Follow up only

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors

Investigator(s): Kereiakes

Follow up only

Efficacy, Immunogenicity, and Safety Study of Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection

Investigator(s): Kereiakes

Follow up only

A Randomized, Double-blind, Multi-center Study to Evaluate the Safety and Efficacy of Oral Sodium Fusidate (CEM-102) Compared to Oral Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infections

Investigator(s): Cafardi

Follow up only

AN OPEN-LABEL EXTENSION STUDY OF DS-5565 FOR 52 WEEKS IN PAIN ASSOCIATED WITH FIBROMYALGIA

Investigator(s): Kereiakes

Follow up only